BLUE - bluebird bio - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart

BLUE is currently covered by 7 analysts with an average potential upside of $14.11 (33.6%) backed by displayed 290 price targets and 265 ratings.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 53.24% with an average time for these price targets to be met of 214.04 days.

Highest price target for BLUE is 10, Lowest price target is 3, average price target is 6.5.

Most recent stock forecast was given by DANE LEONE from RAYMOND JAMES on 08-Nov-2023.

Currently, out of the existing stock ratings of BLUE - 13 which are a Sell (46.43%), 11 which are a Hold (39.29%), 4 which are a Buy (14.29%)

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

13

$9.18 (240.31%)

8

23 days ago

7/9 (77.78%)

$12.37 (73.31%)

90

Buy

6

3 months 22 days ago

2/7 (28.57%)

$3.49 (44.35%)

132

Sell

3

$-0.82 (-21.47%)

3

4 months 20 days ago

10/18 (55.56%)

$2.89 (8.77%)

98

Hold

14

8 months 1 days ago

0/5 (0%)

$14.81 (54.64%)

Hold

8

$4.18 (109.42%)

9

10 months 8 days ago

5/11 (45.45%)

$11.78 (43.56%)

42

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is BLUE (bluebird bio) average time for price targets to be met?

On average it took 214.04 days on average for the stock forecasts to be realized with a an average price target met ratio 53.24

Which analyst has the current highest performing score on BLUE (bluebird bio) with a proven track record?

SALVEEN RICHTER

Which analyst has the most public recommendations on BLUE (bluebird bio)?

Salveen Richter works at GOLDMAN SACHS and has 7 price targets and 4 ratings on BLUE

Which analyst is the currently most bullish on BLUE (bluebird bio)?

Edward Nash with highest potential upside - $108.87

Which analyst is the currently most reserved on BLUE (bluebird bio)?

Matthew Harrison with lowest potential downside - -$0.82

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart